International Solutions For Life Sciences Companies
Advancing Access to Life Changing Therapies
Bringing specialty therapy to patients across international markets is complex. It involves navigating fragmented healthcare systems, differing regulatory environments, and complex supply chains. AscellaHealth's international solutions are built on an integrated ecosystem of affiliates and alliances, giving life sciences companies a single point of coordination across launch and commercialization, wholesale, distribution and patient support.
Our Capabilities
For our clients with international operations, AscellaHealth offers integrated commercial and wholesale distribution services for medicines delivered to hospitals, clinics as well as patients’ homes. Together, they give life sciences companies end-to-end support from market entry through to patient delivery.
Commercialization Services
For life sciences companies looking to launch and commercialize therapies across Europe and the UK, we provide the infrastructure, expertise, and on-the-ground support to make it happen.
Market and regulatory strategy review
Pricing and reimbursement planning
Launch strategy and execution
Comprehensive Wholesale and Distribution
Distribution of medicines in the UK and the EU, with decades of experience navigating country-specific requirements and complex product handling.
Distribution, warehousing, 3PL, importation and export services across 75+ countries
GDP-compliant storage, including temperature-sensitive and cold chain products
Order-to-cash orchestration
Importation/RP(i) services
Direct to Patient Dispensing and Integrated Patient Support Programs
Patient-centric programs that offer care coordination and support patient adherence for specialty therapies that treat rare diseases and complex conditions.
Fully integrated UK homecare services model, including direct-to-patient dispensing, patient support programs, and a UK-wide field nurse network
Custom, branded programs to meet the unique needs of your therapy, disease state and target patient population
Patient journey mapping and program design based on a comprehensive blueprint for highly customized design and intricate program orchestration
Clinical staff dedicated to each program services as a single point of contact for all key stakeholders along a patient’s journey
Unlicensed Sourcing and Patient Access Services
For healthcare stakeholders who need reliable sourcing and distribution of high-value, shortage, or controlled medicines across global markets, CHAPPER healthcare manages the full supply chain and related regulatory compliance.
Named patient supply
Market shortage supply
Clinical trial supply
Compassionate use and early access programs
Our Network
AscellaHealth's International capabilities are powered by a curated network of alliances, offering our partners unparalleled depth of market expertise.
CHAPPER healthcare, an AscellaHealth affiliate, has over five decades of experience with the global sourcing and distributing of specialty, shortage, and controlled medicines, with in-market teams to ensure every shipment meets stringent licensing, compliance, and temperature integrity requirements.
AscellaHealth International is a proud member company of EUROPACCESS — a strategic alliance of leading European pharmaceutical service providers built to deliver integrated commercialization and market access solutions across Europe and the UK.
Actum Pharma is an affiliate of AscellaHealth that provides emerging biopharma cmpanies with a complete, turnkey solution to develop, commercialize, and market emerging specialty therapies in the US and/or Europe.
Ready to Explore a Partnership?
Whether you're looking to expand market access across Europe or the UK, source high-value or shortage medicines globally, or bring specialty therapies to patients faster — AscellaHealth International is ready to work with you.
